Optimizing hormone therapy for future reproductive performance in women with premature ovarian failure
review
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
This review critically appraises current hormone therapy practices for women with premature ovarian failure, focusing on its effect on uterine development and reproductive potential.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
With increasing success in treatment of childhood cancer there is a growing population of women with premature ovarian failure (POF) seeking fertility treatment. Various preparations of estrogen and progestogen are prescribed for young women with POF. While the dose and duration of hormone therapy (HT) is usually adjusted according to the patient's height and the Tanner's stage of development for young pre-pubertal women, the optimal effective HT regimen to maximise the reproductive potential for young as well as for the older age group remains unclear. Furthermore, there is a paucity of evidence to support the preferential effectiveness of the different regimens used. Assisted reproduction using donated gametes or embryos remains the only realistic option to enable women with POF to conceive. Successful outcomes are primarily dependant on successful implantation and placentation. Consequently, the success of assisted reproduction is determined by uterine and endometrial development, which is largely influenced by the modality of HT as well as the age at which it is commenced. In this review, we critically appraise the current practices and published data for management of women with POF. We aim to focus on the effect of HT on uterine development in women with primary and irreversible POF.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
References (75)
- Meeting the needs of young women with secondary amenorrhea and spontaneous premature ovarian failure via openalex
- Successful pregnancies after combined pentoxifylline-tocopherol treatment in women with premature ovarian failure who are resistant to hormone replacement therapy via openalex
- W181681831 via openalex
- W1875380049 via openalex
- W1919166337 via openalex
- W1938874863 via openalex
- W1964079425 via openalex
- W1965234452 via openalex
- W1967199013 via openalex
- W1968318941 via openalex
- W1983539820 via openalex
- W1983617618 via openalex
- W1985280541 via openalex
- W1990329176 via openalex
- W2003327905 via openalex
- W2004382375 via openalex
- W2013199492 via openalex
- W2013723540 via openalex
- W2015756948 via openalex
- W2016406286 via openalex
- W2022349338 via openalex
- W2030469372 via openalex
- W2033289116 via openalex
- W2034638348 via openalex
- W2039225605 via openalex
- W2045604023 via openalex
- W2046986577 via openalex
- W2067617365 via openalex
- W2070108578 via openalex
- W2079591877 via openalex
- W2089375993 via openalex
- W2091077997 via openalex
- W2092440845 via openalex
- W2099750363 via openalex
- W2103284733 via openalex
- W2108947604 via openalex
- W2113259481 via openalex
- W2113547198 via openalex
- W2116759163 via openalex
- W2118379947 via openalex
- W2119533233 via openalex
- W2120922659 via openalex
- W2124171187 via openalex
- W2126506673 via openalex
- W2127332794 via openalex
- W2129411543 via openalex
- W2130013671 via openalex
- W2137252098 via openalex
- W2140596844 via openalex
- W2142132388 via openalex
- W2142558128 via openalex
- W2143152245 via openalex
- W2145283750 via openalex
- W2147047572 via openalex
- W2149652782 via openalex
- W2152860648 via openalex
- W2156005296 via openalex
- W2156333427 via openalex
- W2157823123 via openalex
- W2161404477 via openalex
- W2164228856 via openalex
- W2394569796 via openalex
- W2398382881 via openalex
- W2404316747 via openalex
- W2404599780 via openalex
- W2406305023 via openalex
- W2615004376 via openalex
- W2892286528 via openalex
- W2916269123 via openalex
- W3022719353 via openalex
- W3146905857 via openalex
- W4210970486 via openalex
- W17830691 via openalex
- W4254055538 via openalex
- W175967415 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-10-05T06:32:29.880811+00:00
License: CC0
· commercial use OK